thursdays@3 s2: ep 3 in conversation with tanya quinn, aboriginal health worker
Published 1 year ago • 158 plays • Length 26:41Download video MP4
Download video MP3
Similar videos
-
1:01
what emerald phase iii trial could mean for breast cancer patients | virginia kaklamani, md
-
2:21
the phase 3 tourmaline-mm2 trial
-
4:39
serd vs investigator’s choice of endocrine monotherapy for er /her2-advanced/mbc
-
0:30
the impact of the emerald trial results based on duration of prior cdk4/6i in the metastatic setting
-
17:19
kensuke’s kingdom- ks2 novel (chapter 3)
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
20:56
kensuke’s kingdom- ks2 novel (chapter 7)
-
15:24
kensuke’s kingdom- ks2 novel (chapter 9)
-
4:16
chapter 3: medical care
-
2:54
phase 3 select trial overview
-
1:27
23 s3p2 welcome
-
0:46
update of emerald by duration of cdk4/6i in metastatic setting: elacestrant v soc in er /her2- mbc
-
2:08
chapter 02 - bagpuss
-
2:21
updated results by duration of prior cdk4/6i in the met setting of the phase iii emerald trial
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices
-
10:43
26 s3p2 kesselheim
-
1:00
highlights from the san antonio breast cancer symposium 2022
-
1:27
emerald: elacestrant vs physicians choice in er /her2- breast cancer
-
1:29
the predictive value of treatment response after neoadjuvant therapy